Harlem Community Academic Partnership: Influenza Immunizations

哈莱姆社区学术合作伙伴：流感免疫接种

• 批准号: 8037097
• 负责人: DAVID VLAHOV
• 金额: $ 8.67万
• 依托单位: NEW YORK ACADEMY OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-05-22 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8037097
• 关键词: AIDS prevention; Address; Adopted; Adult; Area; Attitude; Avian Influenza; Awareness; Behavioral Risk Factor Surveillance System; Centers for Disease Control and Prevention (U.S.); Child; Cities; Communities; Community Health; Data; Development; Disadvantaged; Education; Elements; Equipment and supply inventories; Evaluation; Goals; Group Meetings; Health; Health Promotion; Health Surveys; Healthy People 2010; Immunization; Immunization Programs; Influenza; Influenza A Virus, H5N1 Subtype; Influenza vaccination; Intercept; Intervention; Joints; Knowledge; Learning; Measures; Methods; Minority; Mission; Motivation; Mutate; Neighborhoods; New York; New York City; Nurses; Nursing Services; Online Systems; Outcome; Persons; Population; Principal Investigator; Process; Provider; Research Infrastructure; Research Project Grants; Role; Services; Site; Social support; Source; Structure; Surveys; Testing; Trust; Vaccination; Vaccines; Visiting Nurse; Work; Yellow Jackets; base; community based participatory research; design; disorder prevention; experience; high risk; improved; influenza virus vaccine; intervention program; meetings; novel vaccines; outreach; pandemic disease; post intervention; programs; racial and ethnic disparities; response; scale up; social; social health determinants; working group

DESCRIPTION (provided by applicant): Proposed is a community based participatory research project (CBPR) and evaluation for improving influenza immunizations in high risk populations within disadvantaged minority communities. The Harlem Community and Academic Partnership (HCAP)'s Board includes residents, community based organizations, academic partners and the local health department who meet monthly to plan, conduct and review neighborhood assessments, interventions and evaluation activities; topic-specific issues are addressed through formation of Intervention Work Groups (IWGs). The HCAP Board noted especially low rates of influenza immunizations in Harlem and formed the VIVA (Venue Intensive Vaccine for Adults) IWG. This IWG has conducted separate pilots including a survey on barriers to immunization, development of culturally informed intervention materials, a pilot of "yellow jacket" outreach workers to engage and educate hard-to reach populations, and provision of immunizations at non-traditional sites. The goal of this proposal is to assemble these components to formally scale up and test the intervention for adults in the Harlem communities. To achieve these aims, the HCAP VIVA IWG will plan, organize and implement an intervention; our primary partner, Palladia Inc, provides outreach educators and a service network of over 120 CBOs to educate and mobilize the community for immunization as well as coordinate congregating persons with traditional and new non-traditional venues for immunizations; the local Visiting Nurse Service has agreed to provide nurses and influenza vaccines at the selected venues gratis. This program does not replace, but rather supplements existing vaccination programs in the city by adding more relevant education and new "non-traditional" venues. We expect that this program will increase rates of immunizations overall including the hard-to-reach populations. To evaluate this program, we will compare annual rates of immunization between Harlem and communities similar to Harlem in NYC, with data available by neighborhood through the NYC annual "Community Health Survey" (modified BRFSS from CDC) which includes 10,000 adult NYC residents. We will also conduct two cross sectional street intercept surveys (n=800) before and after each annual intervention program between harlem and comparison community residents. These data combined with yearly inventories of CBOs, will provide measures of barriers, intervention experiences and outcomes to broaden input for continuous program improvement.

描述（由申请人提供）：提议的是一个基于社区的参与性研究项目（CBPR）和评估，以改善弱势少数群体社区内高危人群的流感免疫接种。哈莱姆社区和学术合作伙伴 (HCAP) 董事会包括居民、社区组织、学术合作伙伴和当地卫生部门，他们每月举行一次会议，规划、实施和审查社区评估、干预和评估活动；通过组建干预工作组 (IWG) 来解决特定主题的问题。 HCAP 委员会注意到哈莱姆区的流感免疫接种率特别低，并成立了 VIVA（成人场所强化疫苗）IWG。该工作组进行了单独的试点，包括对免疫障碍的调查、开发文化背景的干预材料、“黄夹克”外展工作人员参与和教育难以接触到的人群的试点，以及在非传统地点提供免疫接种。该提案的目标是组装这些组件，以正式扩大和测试对哈莱姆社区成年人的干预措施。为了实现这些目标，HCAP VIVA IWG 将计划、组织和实施干预措施；我们的主要合作伙伴 Palladia Inc 提供外展教育工作者和由 120 多个 CBO 组成的服务网络，以教育和动员社区进行免疫接种，并协调聚集人员与传统和新的非传统免疫接种场所；当地的访问护士服务中心已同意在选定的地点免费提供护士和流感疫苗。该计划不会取代，而是通过增加更多相关教育和新的“非传统”场所来补充该市现有的疫苗接种计划。我们预计该计划将提高整体免疫接种率，包括难以到达的人群。为了评估该计划，我们将比较哈莱姆区和纽约市哈莱姆区类似社区的年免疫接种率，并通过纽约市年度“社区健康调查”（CDC 修改后的 BRFSS）获取各社区的数据，其中包括 10,000 名纽约市成年居民。我们还将在哈莱姆区和对照社区居民之间的每个年度干预计划之前和之后进行两次横断面街道拦截调查（n=800）。这些数据与社区组织的年度清单相结合，将提供障碍、干预经验和结果的衡量标准，以扩大持续项目改进的投入。